Taipan snake venom time for antiphospholipid syndrome solves a 20‐year diagnostic challenge

Click here for the corresponding questions to this CME article.

Saved in:
Bibliographic Details
Published inClinical and experimental dermatology Vol. 45; no. 6; pp. 805 - 808
Main Authors Cunliffe, A., Dobson, J., Swallow, G., Ravenscroft, J., Tang, T. S.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.08.2020
Subjects
Animals
Anticoagulants - administration & dosage
Anticoagulants - therapeutic use
Antiphospholipid syndrome
Antiphospholipid Syndrome - complications
Antiphospholipid Syndrome - diagnosis
Antiphospholipid Syndrome - drug therapy
Autoimmune diseases
Child
Elapid Venoms - chemistry
Elapidae
Factor V - genetics
Humans
Lupus Coagulation Inhibitor - blood
Male
Mutation
Snake Venoms - chemistry
Snakes
Thrombosis - etiology
Thrombosis - prevention & control
Time
Treatment Outcome
Venom
Warfarin - administration & dosage
Warfarin - therapeutic use
Online AccessGet full text

Cover

More Information
Summary:Click here for the corresponding questions to this CME article.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0307-6938
1365-2230
DOI:10.1111/ced.14229